Navigation Links
Medical Affairs Plays Important Role in the Success of New Product Planning Programs
Date:7/27/2012

CHAPEL HILL, N.C., July 27, 2012 /PRNewswire/ -- Pharmaceutical and biotech companies are constantly faced with the challenge of delivering innovative new products at lower development costs. Activities such as ad boards, KOL identification & management, clinical trial strategy & planning, and publication strategy & planning, are central to the new product planning process.

They also represent the activities where organizations turn to Medical Affairs to play a lead role. To give Medical Affairs leaders insights into the timing and value of these activities, Best Practices, LLC conducted research that produced the report "New Product Planning: Role and Activities for Medical Affairs."

In addition to benchmarks that illustrate when organizations conduct Medical Affairs activities in the development cycle, the report provides narratives from new product planning veterans on how organizations approach these critical activities.

This 50-slide report provides drill down for each of these activities in terms of their timing, intended outcomes, and value for the organization:

  • Advisory Boards
  • Branding of the Science
  • KOL Identification
  • KOL Management
  • Medical Meeting Planning
  • Non-Registration Trials Strategy and Planning
  • Publication Strategy & Planning 

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1164.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Disability Advocates Tell Medicare: Use a Clinical Template to Accurately Document Medical Need for Wheelchairs
2. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
3. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
4. Solta Medical Reports Second Quarter Results
5. Rochester Medical Reports Third Quarter Results
6. Plainfield Precision Achieves ISO 13485:2003 Quality Management Certification for Medical Device Manufacturing
7. Medbox, Inc. To Support Referendum Overturning LA City Council Ban on Medical Marijuana Outlets
8. Global Cables and Leads for Medical Equipment Industry
9. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
10. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2012
11. PhytoSPHERE Systems, a Medical Marijuana Inc Portfolio Company, to Bring Production Facilities to Europe through Canipa Holdings.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... , Jan. 23, 2017  HOPE BIOSCIENCES announced ... to develop and commercialize nuc -gemcitabine™ (APTA-12/HOPE-888) ... Korean pharmaceutical company. nuc -Gemcitabine ... against surface nucleolin found on many cancer cells, ... ADCs (antibody drug conjugates) or SMDCs (small molecule ...
(Date:1/23/2017)... ROCKVILLE, Md. , Jan. 23, 2017 /PRNewswire/ ... to advancing a new standard in respiratory care, ... Committee for Orphan Medicinal Products has granted Orphan ... the treatment of Bronchiolitis Obliterans Syndrome (BOS).  ... Drug Designation from the EMA to treat patients ...
(Date:1/23/2017)... Jan. 23, 2017  Based on its recent ... Sullivan recognizes Ansell, a global leader in protection ... Company of the Year Award. Ansell,s comprehensive product ... wide global footprint have placed it in a ... market. The Company,s established product line and robust ...
Breaking Medicine Technology:
(Date:1/24/2017)... , ... January 24, 2017 , ... ... visualize, detect, and eliminate cyber threats in real-time, today announced a strategic partnership ... will enable customers to monitor, respond and protect their critical information assets and ...
(Date:1/24/2017)... ... ... His message has been heard by more than 100,000 students and adults across ... Feldman, has reached his biggest national audience yet: the three million daily readers of ... circulation in the country, and he hopes it will help spread his message and ...
(Date:1/24/2017)... ... January 24, 2017 , ... This Saturday, January 28, the BCFA ... very special performance by Alabama Symphony Orchestra musicians Yifan Zhou, Mara McClain & Sarah ... dim sum, and exhibitors offer a look at Chinese games, crafts & more. Festivities ...
(Date:1/24/2017)... Boston, MA (PRWEB) , ... January 24, 2017 ... ... What They Really Need to Thrive , Well-meaning studies such as the Fordham ... and schools can better serve top students, such as including gifted or high-achieving ...
(Date:1/24/2017)... ... January 24, 2017 , ... Date aired: ... , Sharon Kleyne, the nation’s foremost water advocate and host of the nationally ... Health on Voice America, once again welcomed one of her favorite guests and ...
Breaking Medicine News(10 mins):